I am a plant scientist and R&D strategist with four decades of experience in crop physiology, biotechnology, biomass productivity and research leadership.
My work has focused on a central question in agricultural innovation: why does valuable biological knowledge so often fail to translate into measurable gains in productivity, product quality or commercial impact? This question has shaped much of my scientific, leadership and advisory work.
My scientific foundation is in sugarcane, one of the world’s most productive biomass crops. Through this work I have developed a deep interest in the biological constraints that determine crop performance — including carbon allocation, sink strength, growth regulation, biomass formation, sucrose accumulation and cell wall composition.
These questions are not limited to sugarcane. They are central to many crop, biomass and bioeconomy systems where the goal is to convert biological insight into practical value.
Scientific background
My research career has spanned crop physiology, molecular biology, biotechnology, carbon partitioning, biomass composition and agricultural innovation. I have published extensively in these areas and have worked across the interface between fundamental plant biology and applied crop improvement.
A recurring theme in my work has been the need to connect biological understanding with field performance. Molecular data, omics platforms and discovery research are powerful, but they only create value when they are linked to the real constraints limiting productivity or product quality.
This systems perspective has become increasingly important as agriculture and the bioeconomy face pressure to produce more biomass, higher-value products and more resilient production systems.
Leadership and strategy
In addition to my scientific work, I have held senior leadership roles in agricultural research and innovation. These roles have involved responsibility for research strategy, program design, technology development, national and international collaboration, and translation of science into industry outcomes.
This experience has given me a practical understanding of how R&D programs succeed — and where they often lose momentum.
Common problems include:
- discovery projects that are poorly connected to production constraints
- technology pipelines that are not aligned with commercial or industry needs
- unrealistic assumptions about time to delivery
- insufficient attention to biological bottlenecks
- weak links between laboratory insight, field validation and deployment
My advisory work helps organisations identify these issues early and reposition their programs for stronger impact.
How I work
I bring a combination of scientific depth, strategic analysis and practical R&D experience.
My approach is to start with the real-world objective and work backwards:
What is the desired outcome?
Where is the biological or technical constraint?
Is the current R&D pipeline aligned with that constraint?
What evidence is needed to make better investment or development decisions?
This often means moving across scales — from genes and metabolism to whole-plant physiology, field performance, processing quality and commercial value.
The aim is not simply to generate more data. The aim is to improve decisions.
Areas of interest
My current advisory and writing interests include:
- biomass productivity and crop improvement strategy
- carbon allocation, sink strength and growth constraints
- alignment of discovery research with field and commercial outcomes
- R&D portfolio review and technology pipeline design
- sugarcane, energy crops and biomass-based production systems
- translation of plant science into bioeconomy opportunities
- critical review of assumptions in biomass processing and value chains
Perspective
I believe that some of the most important opportunities in crop innovation will come from asking better questions about biological constraints.
More data alone will not solve the productivity challenge. Progress depends on knowing where the real constraint sits — and aligning research, technology development and investment around that constraint.
That is the perspective I bring to advisory work.